Adjuvant FOLFIRI with or without cetuximab in patients with resected stage III colon cancer: NCCTG Intergroup phase III trial N0147.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. Huang, D. J. Sargent, M. R. Mahoney, S. N. Thibodeau, T. C. Smyrk, F. Sinicrope, G. D. Nelson, S. R. Alberts
Institution: Mayo Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591207677
